YP
LAB icon

YANKCOM Partnership’s Standard BioTools LAB Stock Holding History

YANKCOM Partnership’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-94
Closed -$86 – 351
2026
Q1 		$86 Hold
94
– – ﹤0.01% 366
2025
Q4 		$120 Buy
+94
New +$126 ﹤0.01% 374

Other funds holding LAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

YANKCOM Partnership's LAB Position: Q2 2026 in Review

YANKCOM Partnership sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 94 shares — an estimated $86 sold.

YANKCOM Partnership first reported a position in LAB in Q4 2025 and held it in 2 quarters. The position peaked at $120 in Q4 2025. 40 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • YANKCOM Partnership reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • YANKCOM Partnership sold 94 Standard BioTools shares in Q2 2026, an estimated $86.
  • YANKCOM Partnership first reported a position in Standard BioTools in Q4 2025 and held it in 2 quarters.
  • YANKCOM Partnership's Standard BioTools position peaked at $120 in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.